Sep 17, 2018 - Is Grifols, S.A. (GRFS) a great pick from the value investor's perspective right now? Read on to know more.
Sep 12, 2018 - Gilead took September's net gain safer Healthcare WallStar top spot. Its projected 21.82% net gain was 3% better than AbbVie's, and 29% more than Grifol's result, per analyst targets 9/10/18.WallStars
Sep 12, 2018 - But for PMD, Big pharma drug makers and biotech continued to top the healthcare sector by yield and broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare s
Jun 01, 2018 - Barclays issues rating change for GRFS
May 31, 2018 - Grifols S.A. (NASDAQ:GRFS) had declared $0.250975/share semi-annual dividend.Payable June 5; for shareholders of record May 31; ex-div June 1.
May 24, 2018 - Gilead took net gain safer May dividend Healthcare WallStar honors. Its 27.4% net gain was 23% better than Sanofi's, and 32% ahead of AmerisourceBergen's result per analyst targets of 5/22/18.22 of 31
May 22, 2018 - Payments processor serving the niche plasma donation market. Share winner in a growing industry with revenue potentially 4-8x higher in four years.Strong financial profile with high margins, ROIC, and
May 09, 2018 - Engadine Partners LLP Buys Grifols SA, Monster Beverage Corp, Sells GCP Applied Technologies Inc, Coca-Cola European Partners PLC, Stocks: GRFS,MNST,GCP,CCE,, release date:May 09, 2018
Apr 10, 2018 - Sales and earnings growth have been tremendous.Profit margins were over 15% last year.The annual report was just released.The stock may be down on worries with China trade.
Mar 12, 2018 - Aradigm and Grifols try for European approval.Pfizer's GI advisory committee goes rather smoothly.VBL Therapeutics fails on glioblastoma treatment.